JP2007525520A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007525520A5 JP2007525520A5 JP2007501005A JP2007501005A JP2007525520A5 JP 2007525520 A5 JP2007525520 A5 JP 2007525520A5 JP 2007501005 A JP2007501005 A JP 2007501005A JP 2007501005 A JP2007501005 A JP 2007501005A JP 2007525520 A5 JP2007525520 A5 JP 2007525520A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- unsaturated
- alkyl
- heterocycle
- heteroatoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 86
- 229920006395 saturated elastomer Polymers 0.000 claims 85
- 125000005842 heteroatom Chemical group 0.000 claims 67
- 125000000623 heterocyclic group Chemical group 0.000 claims 59
- 229910052760 oxygen Inorganic materials 0.000 claims 54
- 125000003118 aryl group Chemical group 0.000 claims 51
- 229910052717 sulfur Inorganic materials 0.000 claims 51
- 229910052757 nitrogen Inorganic materials 0.000 claims 50
- DDMOUSALMHHKOS-UHFFFAOYSA-N 1,2-dichloro-1,1,2,2-tetrafluoroethane Chemical compound FC(F)(Cl)C(F)(F)Cl DDMOUSALMHHKOS-UHFFFAOYSA-N 0.000 claims 47
- 125000000217 alkyl group Chemical group 0.000 claims 47
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 45
- 239000001301 oxygen Substances 0.000 claims 45
- 150000001875 compounds Chemical class 0.000 claims 44
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 42
- 239000011593 sulfur Substances 0.000 claims 42
- 239000000203 mixture Substances 0.000 claims 21
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 20
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 19
- 125000004429 atom Chemical group 0.000 claims 19
- 125000001072 heteroaryl group Chemical group 0.000 claims 14
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 13
- 125000000304 alkynyl group Chemical group 0.000 claims 13
- 239000003120 macrolide antibiotic agent Substances 0.000 claims 13
- 229910052799 carbon Inorganic materials 0.000 claims 12
- 125000003342 alkenyl group Chemical group 0.000 claims 11
- 150000001204 N-oxides Chemical class 0.000 claims 10
- 150000002148 esters Chemical class 0.000 claims 10
- 239000000651 prodrug Substances 0.000 claims 10
- 229940002612 prodrug Drugs 0.000 claims 10
- 150000003839 salts Chemical class 0.000 claims 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 9
- 241000124008 Mammalia Species 0.000 claims 9
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 9
- 125000003545 alkoxy group Chemical group 0.000 claims 8
- 125000002252 acyl group Chemical group 0.000 claims 7
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 6
- 125000004122 cyclic group Chemical group 0.000 claims 5
- 229910052731 fluorine Inorganic materials 0.000 claims 5
- 229910052736 halogen Inorganic materials 0.000 claims 5
- 150000002367 halogens Chemical class 0.000 claims 5
- 229910052740 iodine Inorganic materials 0.000 claims 5
- 239000000126 substance Substances 0.000 claims 5
- 125000003107 substituted aryl group Chemical group 0.000 claims 5
- 229910052794 bromium Inorganic materials 0.000 claims 4
- 150000001721 carbon Chemical group 0.000 claims 4
- 125000004432 carbon atom Chemical group C* 0.000 claims 4
- 229910052801 chlorine Inorganic materials 0.000 claims 4
- 229910052739 hydrogen Inorganic materials 0.000 claims 4
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 claims 3
- 125000001054 5 membered carbocyclic group Chemical group 0.000 claims 3
- 125000004008 6 membered carbocyclic group Chemical group 0.000 claims 3
- 125000004649 C2-C8 alkynyl group Chemical group 0.000 claims 3
- 125000004414 alkyl thio group Chemical group 0.000 claims 3
- 125000002619 bicyclic group Chemical group 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims 3
- KIWSYRHAAPLJFJ-DNZSEPECSA-N n-[(e,2z)-4-ethyl-2-hydroxyimino-5-nitrohex-3-enyl]pyridine-3-carboxamide Chemical compound [O-][N+](=O)C(C)C(/CC)=C/C(=N/O)/CNC(=O)C1=CC=CN=C1 KIWSYRHAAPLJFJ-DNZSEPECSA-N 0.000 claims 3
- 125000001424 substituent group Chemical group 0.000 claims 3
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 2
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 claims 2
- 125000004648 C2-C8 alkenyl group Chemical group 0.000 claims 2
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 150000001336 alkenes Chemical class 0.000 claims 2
- 125000005841 biaryl group Chemical group 0.000 claims 2
- 125000002837 carbocyclic group Chemical group 0.000 claims 2
- 150000002118 epoxides Chemical group 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 230000035772 mutation Effects 0.000 claims 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims 1
- 206010017533 Fungal infection Diseases 0.000 claims 1
- 208000017228 Gastrointestinal motility disease Diseases 0.000 claims 1
- 208000031888 Mycoses Diseases 0.000 claims 1
- 208000030852 Parasitic disease Diseases 0.000 claims 1
- 208000036142 Viral infection Diseases 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 150000002016 disaccharides Chemical class 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000006575 electron-withdrawing group Chemical group 0.000 claims 1
- 229930182470 glycoside Natural products 0.000 claims 1
- 150000002338 glycosides Chemical class 0.000 claims 1
- -1 halo sugars Chemical class 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 208000027866 inflammatory disease Diseases 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
- 230000000813 microbial effect Effects 0.000 claims 1
- 125000002950 monocyclic group Chemical group 0.000 claims 1
- 150000002772 monosaccharides Chemical class 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000002062 proliferating effect Effects 0.000 claims 1
- 235000000346 sugar Nutrition 0.000 claims 1
- 230000009385 viral infection Effects 0.000 claims 1
- 0 C*=C(C)[*@]([C@](C(C(*)O[C@]1OIC)OC(NN*)=C)[C@]1OCC=*)C=I Chemical compound C*=C(C)[*@]([C@](C(C(*)O[C@]1OIC)OC(NN*)=C)[C@]1OCC=*)C=I 0.000 description 10
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54828004P | 2004-02-27 | 2004-02-27 | |
| US60/548,280 | 2004-02-27 | ||
| US57594904P | 2004-06-01 | 2004-06-01 | |
| US60/575,949 | 2004-06-01 | ||
| PCT/US2005/006082 WO2005085266A2 (en) | 2004-02-27 | 2005-02-25 | Macrocyclic compounds and methods of making and using the same |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012034350A Division JP5631909B2 (ja) | 2004-02-27 | 2012-02-20 | 大環状化合物およびそれらを製造し使用する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007525520A JP2007525520A (ja) | 2007-09-06 |
| JP2007525520A5 true JP2007525520A5 (https=) | 2008-04-03 |
| JP5383037B2 JP5383037B2 (ja) | 2014-01-08 |
Family
ID=34922681
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007501005A Expired - Fee Related JP5383037B2 (ja) | 2004-02-27 | 2005-02-25 | 大環状化合物およびそれらを製造し使用する方法 |
| JP2012034350A Expired - Fee Related JP5631909B2 (ja) | 2004-02-27 | 2012-02-20 | 大環状化合物およびそれらを製造し使用する方法 |
| JP2014161364A Pending JP2014208707A (ja) | 2004-02-27 | 2014-08-07 | 大環状化合物およびそれらを製造し使用する方法 |
| JP2016136733A Pending JP2017019786A (ja) | 2004-02-27 | 2016-07-11 | 大環状化合物およびそれらを製造し使用する方法 |
| JP2018009418A Pending JP2018104437A (ja) | 2004-02-27 | 2018-01-24 | 大環状化合物およびそれらを製造し使用する方法 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012034350A Expired - Fee Related JP5631909B2 (ja) | 2004-02-27 | 2012-02-20 | 大環状化合物およびそれらを製造し使用する方法 |
| JP2014161364A Pending JP2014208707A (ja) | 2004-02-27 | 2014-08-07 | 大環状化合物およびそれらを製造し使用する方法 |
| JP2016136733A Pending JP2017019786A (ja) | 2004-02-27 | 2016-07-11 | 大環状化合物およびそれらを製造し使用する方法 |
| JP2018009418A Pending JP2018104437A (ja) | 2004-02-27 | 2018-01-24 | 大環状化合物およびそれらを製造し使用する方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (4) | US8202843B2 (https=) |
| EP (2) | EP2716647A3 (https=) |
| JP (5) | JP5383037B2 (https=) |
| CN (1) | CN102816194A (https=) |
| WO (1) | WO2005085266A2 (https=) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR043050A1 (es) | 2002-09-26 | 2005-07-13 | Rib X Pharmaceuticals Inc | Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos |
| JP5383037B2 (ja) | 2004-02-27 | 2014-01-08 | リブ−エックス ファーマシューティカルズ，インコーポレイテッド | 大環状化合物およびそれらを製造し使用する方法 |
| DE102004045870A1 (de) * | 2004-04-07 | 2005-12-01 | Dynamit Nobel Gmbh Explosivstoff- Und Systemtechnik | Verfahren zur Herstellung von Azidoalkylaminen |
| EP1807439A2 (en) * | 2004-10-25 | 2007-07-18 | Ranbaxy Laboratories Limited | Ketolide derivatives as antibacterial agents |
| UA90720C2 (en) * | 2005-05-25 | 2010-05-25 | Басф Акциенгезелльшафт | Heteroaroyl-substituted serine amides |
| EP3290427A1 (en) * | 2005-08-24 | 2018-03-07 | Melinta Therapeutics, Inc. | Triazole compounds and methods of making and using the same |
| JP2009506063A (ja) * | 2005-08-24 | 2009-02-12 | リブ−エックス ファーマシューティカルズ，インコーポレイテッド | トリアゾール化合物ならびにこれを作製する方法および使用する方法 |
| WO2007054904A2 (en) * | 2005-11-08 | 2007-05-18 | Ranbaxy Laboratories Limited | Macrolides as anti-inflammatory agents |
| WO2007060518A2 (en) * | 2005-11-23 | 2007-05-31 | Ranbaxy Laboratories Limited | Ketolide derivatives as antibacterial agents |
| EA017878B1 (ru) * | 2006-12-12 | 2013-03-29 | Замбон С.П.А. | Макролидные соединения, обладающие противовоспалительной активностью |
| WO2008106224A1 (en) * | 2007-02-28 | 2008-09-04 | Rib-X Pharmaceuticals, Inc. | Macrolide compounds and methods of making and using the same |
| CA2733706A1 (en) * | 2007-08-10 | 2009-02-19 | Y's Therapeutics Co., Ltd. | Modulation of immune responses by administration of roxithromycin or its derivative |
| JP2011529977A (ja) | 2008-07-31 | 2011-12-15 | スリーエム イノベイティブ プロパティズ カンパニー | フルオロポリマー組成物並びにその製造及び使用方法 |
| EP2315802A4 (en) * | 2008-07-31 | 2012-04-18 | 3M Innovative Properties Co | AZIUM COMPOSITIONS AND METHOD FOR THEIR PREPARATION AND USE |
| WO2011018510A1 (en) | 2009-08-13 | 2011-02-17 | Basilea Pharmaceutica Ag | New macrolides and their use |
| JP2013506676A (ja) * | 2009-09-30 | 2013-02-28 | トランザイム・ファーマ，インコーポレイテッド | 大環状グレリン受容体アゴニストの塩、溶媒和物、および薬学的組成物、ならびにその使用方法 |
| EP2694707B1 (en) | 2011-04-07 | 2018-08-15 | Cornell University | Monomers capable of dimerizing in an aqueous solution, and methods of using same |
| PT2782922T (pt) * | 2011-11-25 | 2018-02-05 | The Kitasato Inst | Derivados antibacterianos de tilosina e processos para a sua preparação |
| WO2017150341A1 (ja) * | 2016-03-04 | 2017-09-08 | 株式会社カネカ | アーク防護服用布帛及びアーク防護服 |
| WO2018191682A1 (en) * | 2017-04-15 | 2018-10-18 | Melinta Therapeutics, Inc. | Triazole compounds and methods of making and using the same |
| CU24717B1 (es) | 2018-10-02 | 2024-08-15 | Lunella Biotech Inc | Derivados de azitromicina y roxitromicina como fármacos senolíticos |
Family Cites Families (117)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3629232A (en) | 1969-08-19 | 1971-12-21 | Abbott Lab | 2'-o-alkanoyl-4'-alkanoyloxy derivatives of erythromycin |
| US3681325A (en) | 1970-09-30 | 1972-08-01 | Abbott Lab | De(n-methyl)-n-substituted derivatives of erythromycin |
| US4404201A (en) | 1981-11-13 | 1983-09-13 | Warner-Lambert Company | Cephalosporins |
| US4546176A (en) | 1982-12-14 | 1985-10-08 | Eisai Co., Ltd. | 7-Carboxymethoxyphenylacetamido-3-cephem derivatives and antibacterial preparations containing the same |
| US5008249A (en) | 1985-08-31 | 1991-04-16 | Kitasato Kenkyusho | Therapeutic method of stimulating digestive tract contractile motion in mammals |
| EP0215355B1 (en) | 1985-08-31 | 1994-04-06 | Kitasato Kenkyusho | Erythromycin derivative and process for preparing the same |
| US5232918A (en) | 1987-07-23 | 1993-08-03 | Imperial Chemical Industries Plc | Cephalosporin derivatives |
| US5336768A (en) | 1988-05-24 | 1994-08-09 | Hoffmann-La Roche Inc. | Antibacterial cephalosporin compounds |
| US5180719A (en) | 1988-10-24 | 1993-01-19 | Norwich Eaton Pharmaceuticals, Inc. | Antimicrobial quinolonyl lactam esters |
| US6446032B1 (en) | 1990-09-21 | 2002-09-03 | Massachusetts Institute Of Technology | Designing compounds specifically inhibiting ribonucleic acid by binding to the minor groove |
| IL114589A (en) | 1990-11-21 | 1999-12-22 | Roussel Uclaf | Intermediates for the preparation of erythromycin derivatives |
| US5686065A (en) | 1991-03-27 | 1997-11-11 | Special Advanced Biomaterials, Inc. | Topical siloxane sunscreen compositions having enhanced performance and safety |
| ES2101119T3 (es) | 1991-10-01 | 1997-07-01 | Procter & Gamble Pharma | Procedimiento para preparar quinolonil-lactamas antimicrobianas. |
| US5215980A (en) | 1992-01-17 | 1993-06-01 | Merck & Co., Inc. | 10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives thereof |
| MY113693A (en) * | 1992-05-26 | 2002-05-31 | Chugai Pharmaceutical Co Ltd | Erythromycin derivatives having an enterokinesis stimulating action |
| TW355711B (en) | 1992-11-04 | 1999-04-11 | Chugai Pharmaceutical Co Ltd | Erythromycin derivatives |
| FR2697524B1 (fr) | 1992-11-05 | 1994-12-23 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
| US5527780A (en) | 1992-11-05 | 1996-06-18 | Roussel Uclaf | Erythromycin derivatives |
| MY115155A (en) | 1993-09-09 | 2003-04-30 | Upjohn Co | Substituted oxazine and thiazine oxazolidinone antimicrobials. |
| FR2719587B1 (fr) | 1994-05-03 | 1996-07-12 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
| IT1276901B1 (it) | 1994-12-13 | 1997-11-03 | Zambon Spa | Derivati dell'eritromicina a 9-0-ossina dotati di attivita' antibiotica |
| US5693791A (en) | 1995-04-11 | 1997-12-02 | Truett; William L. | Antibiotics and process for preparation |
| US6274715B1 (en) | 1995-11-08 | 2001-08-14 | Abbott Laboratories | Tricyclic erythromycin derivatives |
| US5891643A (en) | 1995-11-14 | 1999-04-06 | Abbott Laboratories | Use of nuclear magnetic resonance to design ligands to target biomolecules |
| FR2742757B1 (fr) | 1995-12-22 | 1998-01-30 | Roussel Uclaf | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
| DE19604223A1 (de) | 1996-02-06 | 1997-08-07 | Bayer Ag | Neue substituierte Oxazolidinone |
| WO1997035195A1 (en) | 1996-03-19 | 1997-09-25 | The Salk Institute For Biological Studies | In vitro methods for identifying modulators of members of the steroid/thyroid superfamily of receptors |
| FR2748746B1 (fr) * | 1996-05-14 | 1998-08-14 | Hoechst Marion Roussel Inc | Nouveau procede d'isomerisation du radical methyle en 10 de derives de l'erythromycine |
| US5712253A (en) | 1996-06-18 | 1998-01-27 | Abbott Laboratories | Macrocyclic 13-membered ring derivatives of erythromycins A and B |
| UA51730C2 (uk) | 1996-09-04 | 2002-12-16 | Ебботт Лабораторіз | 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців |
| HN1998000074A (es) | 1997-06-11 | 1999-01-08 | Pfizer Prod Inc | Derivados de macrolidos c-4 sustituidos |
| CZ9904388A3 (cs) | 1997-06-11 | 2002-10-16 | Pfizer Products Inc. | 9-Oximové deriváty erythromycinu |
| EP0895999A1 (en) | 1997-08-06 | 1999-02-10 | Pfizer Products Inc. | C-4" substituted macrolide antibiotics |
| US5780605A (en) | 1997-09-08 | 1998-07-14 | Abbott Laboratories | 6,9-bridged erythromycin derivatives |
| DK1025114T3 (da) * | 1997-09-30 | 2004-07-05 | Abbott Lab | 3'-N-modificerede 6-O-substituerede erythromycin-ketolidderivater med antibakteriel aktivitet |
| US6034069A (en) | 1997-09-30 | 2000-03-07 | Abbott Laboratories | 3-'N-modified 6-O-substituted erythromycin ketolide derivatives having antibacterial activity |
| ZA989885B (en) * | 1997-10-31 | 1999-05-05 | Abbott Lab | Use of macrolides for the treatment of cancer and macular degeneration |
| WO1999028308A1 (en) | 1997-11-29 | 1999-06-10 | Truett William L | Antibiotics and process for preparation |
| AU1694099A (en) | 1997-12-26 | 1999-07-19 | Cheil Jedang Corporation | Cephem derivatives and a method for producing the compounds and an antibacterialcomposition containing the compounds |
| US5955440A (en) | 1998-03-27 | 1999-09-21 | Abbott Laboratories | Macrolide LHRH antagonists |
| US6437119B1 (en) | 1998-05-07 | 2002-08-20 | William Lawrence Truett | Compounds formed from two or three antibiotics and their processes of preparation |
| TR200003595T2 (tr) | 1998-06-05 | 2001-07-23 | Astrazeneca Ab | Kimyasal bileşikler |
| GB9812019D0 (en) | 1998-06-05 | 1998-07-29 | Zeneca Ltd | Chemical compounds |
| WO1999063929A2 (en) | 1998-06-08 | 1999-12-16 | Advanced Medicine, Inc. | Multibinding inhibitors of microsomal triglyceride transferase protein |
| EP1086065A4 (en) | 1998-06-08 | 2001-03-28 | Advanced Medicine Inc | Combinatorial synthesis of multibinding libraries |
| US6541669B1 (en) | 1998-06-08 | 2003-04-01 | Theravance, Inc. | β2-adrenergic receptor agonists |
| WO1999063994A1 (en) | 1998-06-08 | 1999-12-16 | Advanced Medicine, Inc. | MULTIBINDING INHIBITORS OF HMG-CoA REDUCTASE |
| US6420354B1 (en) | 1998-06-08 | 2002-07-16 | Advanced Medicine, Inc. | Sodium channel drugs and uses |
| EP1085845A2 (en) | 1998-06-08 | 2001-03-28 | Advanced Medicine, Inc. | Multibinding inhibitors of cyclooxygenase-2 |
| IT1301968B1 (it) | 1998-07-30 | 2000-07-20 | Zambon Spa | Derivati di eritromicina ad attivita' antibiotica |
| US6020521A (en) | 1998-08-26 | 2000-02-01 | Abbott Laboratories | Macrolide LHRH antagonists |
| GB9821938D0 (en) | 1998-10-09 | 1998-12-02 | Zeneca Ltd | Chemical compounds |
| HRP980646B1 (en) * | 1998-12-30 | 2008-02-29 | GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. | Novel oleandomycin derivatives |
| IT1306205B1 (it) | 1999-01-15 | 2001-05-30 | Zambon Spa | Macrolidi ad attivita' antiinfiammatoria. |
| US6479498B1 (en) | 1999-06-04 | 2002-11-12 | Theravance, Inc. | Sodium channel drugs and uses |
| HRP990192A2 (en) | 1999-06-11 | 2001-04-30 | Pliva D D | 4'-DEMICAROZYL-8a-AZA-8a-HOMOTHILOSINE DERIVATIVES |
| US6413981B1 (en) | 1999-08-12 | 2002-07-02 | Ortho-Mcneil Pharamceutical, Inc. | Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods |
| GB9928568D0 (en) | 1999-12-03 | 2000-02-02 | Zeneca Ltd | Chemical compounds |
| IT1314261B1 (it) | 1999-12-03 | 2002-12-06 | Enichem Spa | Composti metallocenici pontati, processo per la loro preparazione eloro uso come catalizzatori per la polimerizzazione di olefine. |
| GB9928499D0 (en) | 1999-12-03 | 2000-02-02 | Zeneca Ltd | Chemical processes and intermediates |
| JP2003522763A (ja) | 2000-02-10 | 2003-07-29 | ファルマシア・アンド・アップジョン・カンパニー | ピペラジンアミド置換基を持つオキサゾリジノンチオアミド |
| JP2001261694A (ja) | 2000-03-06 | 2001-09-26 | Pfizer Prod Inc | ケトライド抗生物質 |
| GB0009803D0 (en) | 2000-04-25 | 2000-06-07 | Astrazeneca Ab | Chemical compounds |
| EP1299109B1 (en) | 2000-04-27 | 2009-07-15 | The Scripps Research Institute | Bifunctional antibiotics |
| DE10034627A1 (de) | 2000-07-17 | 2002-01-31 | Bayer Ag | Aryl-substituierte Oxazolidinone mit Cytokin inhibitorischer Wirkung |
| IL180679A0 (en) | 2000-10-27 | 2009-02-11 | Pfizer Prod Inc | Process for the preparation of non-steroidal glucocorticoid receptor modulators |
| ES2262612T3 (es) | 2000-10-28 | 2006-12-01 | Pfizer Products Inc. | Moduladpres del receptor de glucocorticoides. |
| AU2002225724A1 (en) * | 2000-12-01 | 2002-07-08 | Kosan Biosciences, Inc. | Motilide compounds |
| US6440942B1 (en) | 2000-12-22 | 2002-08-27 | Enanta Pharmaceuticals, Inc. | 14-membered macrolides derived from leucomycins |
| GB0108764D0 (en) | 2001-04-07 | 2001-05-30 | Astrazeneca Ab | Chemical compounds |
| ES2268011T3 (es) | 2001-04-07 | 2007-03-16 | Astrazeneca Ab | Oxazolidinonas que contienen un grupo sulfonimida como antibioticos. |
| GB0108793D0 (en) | 2001-04-07 | 2001-05-30 | Astrazeneca Ab | Chemical compounds |
| GB0108794D0 (en) | 2001-04-07 | 2001-05-30 | Astrazeneca Ab | Chemical compound |
| GB0113299D0 (en) | 2001-06-01 | 2001-07-25 | Astrazeneca Ab | Chemical process & intermediates |
| GB0113297D0 (en) | 2001-06-01 | 2001-07-25 | Astrazeneca Ab | Chemical Process |
| US6680299B2 (en) | 2001-07-27 | 2004-01-20 | Enanta Pharmaceuticals, Inc. | 4'-substituted leucomycins |
| US20030158093A1 (en) | 2001-08-17 | 2003-08-21 | Binyuan Sun | Bifunctional glycopeptide antibiotics and combinatorial libararies thereof |
| US7396847B2 (en) | 2001-09-11 | 2008-07-08 | Astrazeneca Ab | Oxazolidinone and/or isoxazoline as antibacterial agents |
| EP1443930A1 (en) | 2001-10-25 | 2004-08-11 | AstraZeneca AB | Isoxazoline derivatives useful as antimicrobials |
| GB2396350A (en) | 2001-10-25 | 2004-06-23 | Astrazeneca Ab | Aryl substituted oxazolidinones with antibacterial activity |
| US6576615B2 (en) | 2001-11-08 | 2003-06-10 | Enanta Pharmaceuticals, Inc. | 4′-O-substituted tylosin analogs |
| GB0127349D0 (en) | 2001-11-14 | 2002-01-02 | Glaxo Group Ltd | Macrolides |
| US6664240B2 (en) | 2001-11-15 | 2003-12-16 | Enanta Pharmaceuticals, Inc. | Tylosin derivatives having antibacterial activity |
| PL371335A1 (en) | 2002-01-22 | 2005-06-13 | Pharmacia & Upjohn Company | Infection-resistant medical devices |
| AU2003211113B2 (en) | 2002-02-15 | 2007-08-09 | Merckle Gmbh | Antibiotic conjugates |
| WO2003070173A2 (en) | 2002-02-15 | 2003-08-28 | Sympore Gmbh | Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof |
| AU2003219770B2 (en) | 2002-02-15 | 2008-10-09 | Merckle Gmbh | Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof |
| JP2005524661A (ja) | 2002-02-28 | 2005-08-18 | アストラゼネカ アクチボラグ | ３−シクリル−５−（窒素含有５員環）メチル−オキサゾリジノン誘導体と抗菌剤としてのその使用 |
| US6710034B2 (en) | 2002-04-19 | 2004-03-23 | Enanta Pharmaceuticals, Inc. | 5-O-mycaminosyltylonide derivatives |
| US6753415B2 (en) | 2002-04-19 | 2004-06-22 | Enanta Pharmaceuticals, Inc. | 23-O-substituted 5-O-mycaminosyltylonide derivatives |
| US6878691B2 (en) | 2002-05-13 | 2005-04-12 | Enanta Pharmaceuticals, Inc. | 6-11 bicyclic ketolide derivatives |
| US7064110B2 (en) | 2002-05-13 | 2006-06-20 | Enanta Pharmaceuticals, Inc. | 6-11 bicycle ketolide derivatives |
| KR100661973B1 (ko) | 2002-05-13 | 2006-12-28 | 이난타 파마슈티칼스, 인코포레이티드 | 6,11 바이사이클릭 에리스로마이신 유도체 |
| RU2330858C2 (ru) | 2002-07-08 | 2008-08-10 | Глаксомитклайн Истраживацки Центар Загреб Д.О.О. | Новые соединения, составы и способы лечения воспалительных заболеваний и состояний |
| PL374646A1 (en) | 2002-07-08 | 2005-10-31 | Pliva-Istrazivacki Institutt D.O.O. | Novel nonsteroidal anti-inflammatory substances, compositions and methods for their use |
| US7157433B2 (en) | 2002-07-08 | 2007-01-02 | Glaxosmithkline Istrazivacki Centar Zagreb | Compounds, compositions as carriers for steroid/nonsteroid anti-inflammatory; antienoplastic and antiviral active molecules |
| ITMI20021726A1 (it) * | 2002-08-01 | 2004-02-02 | Zambon Spa | Macrolidi ad attivita' antiinfiammatoria. |
| AR043050A1 (es) | 2002-09-26 | 2005-07-13 | Rib X Pharmaceuticals Inc | Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos |
| HRP20020886A2 (en) | 2002-11-11 | 2005-06-30 | PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. | SUBSTITUTED 9a-N-[N'-(BENZENSULFONYL)CARBAMOYL-γ-AMINOPROPYL) AND 9a-N(N' -(?-CYANOETHIL)-N' -(b |
| US20060116400A1 (en) | 2002-11-28 | 2006-06-01 | Astrazeneca Ab | Oxazolidinone and/or isoxazoline derivatives as antibacterial agents |
| GB0229526D0 (en) | 2002-12-19 | 2003-01-22 | Astrazeneca Ab | Chemical compounds |
| GB0229518D0 (en) | 2002-12-19 | 2003-01-22 | Astrazeneca Ab | Chemical compounds |
| GB0229521D0 (en) | 2002-12-19 | 2003-01-22 | Astrazeneca Ab | Chemical compounds |
| CN1780846A (zh) | 2003-03-05 | 2006-05-31 | Rib－X医药品有限公司 | 双官能杂环化合物及其制备和使用方法 |
| ES2552682T3 (es) | 2003-03-10 | 2015-12-01 | Merck Sharp & Dohme Corp. | Agentes antibacterianos novedosos |
| HRP20030324A2 (en) | 2003-04-24 | 2005-02-28 | Pliva-Istra�iva�ki institut d.o.o. | Compounds of antiinflammatory effect |
| NZ543757A (en) | 2003-04-30 | 2009-02-28 | Morphochem Ag Komb Chemie | Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections |
| WO2004108745A2 (en) | 2003-06-05 | 2004-12-16 | Enanta Pharmaceuticals, Inc. | 11-12 bicyclic erythromycin derivatives |
| US20040254126A1 (en) | 2003-06-05 | 2004-12-16 | Yao-Ling Qiu | 11-12 Bicyclic erythromycin derivatives |
| US20070270484A1 (en) | 2003-09-25 | 2007-11-22 | Biswajit Das | 3'-N-Substituted-3-O-Substituted Erythronolide a Derivatives |
| WO2005042554A1 (en) * | 2003-10-30 | 2005-05-12 | Rib-X Pharmaceuticals, Inc. | Bifunctional macrolide heterocyclic compounds and methods of making and using the same |
| JP2007512256A (ja) | 2003-11-18 | 2007-05-17 | リブ−エックス ファーマシューティカルズ，インコーポレイテッド | 二官能性マクロライド複素環化合物ならびにこれらを製造する方法およびこれらを使用する方法 |
| ITMI20040124A1 (it) | 2004-01-29 | 2004-04-29 | Zambon Spa | Macrolidi ad attivita' antiinfiammatoria |
| JP5383037B2 (ja) | 2004-02-27 | 2014-01-08 | リブ−エックス ファーマシューティカルズ，インコーポレイテッド | 大環状化合物およびそれらを製造し使用する方法 |
| WO2005118610A2 (en) | 2004-06-01 | 2005-12-15 | Rib-X Pharmaceuticals, Inc. | Macrocyclic compounds and methods of making and using the same |
| JP2009506063A (ja) | 2005-08-24 | 2009-02-12 | リブ−エックス ファーマシューティカルズ，インコーポレイテッド | トリアゾール化合物ならびにこれを作製する方法および使用する方法 |
| EP3290427A1 (en) | 2005-08-24 | 2018-03-07 | Melinta Therapeutics, Inc. | Triazole compounds and methods of making and using the same |
-
2005
- 2005-02-25 JP JP2007501005A patent/JP5383037B2/ja not_active Expired - Fee Related
- 2005-02-25 EP EP13178998.4A patent/EP2716647A3/en not_active Withdrawn
- 2005-02-25 WO PCT/US2005/006082 patent/WO2005085266A2/en not_active Ceased
- 2005-02-25 EP EP05723790.1A patent/EP1723159B1/en not_active Expired - Lifetime
- 2005-02-25 US US10/590,782 patent/US8202843B2/en not_active Expired - Fee Related
- 2005-02-25 CN CN2012102533942A patent/CN102816194A/zh active Pending
-
2012
- 2012-02-20 JP JP2012034350A patent/JP5631909B2/ja not_active Expired - Fee Related
- 2012-06-18 US US13/525,900 patent/US8841263B2/en not_active Expired - Lifetime
-
2014
- 2014-07-09 US US14/327,452 patent/US20150158901A1/en not_active Abandoned
- 2014-08-07 JP JP2014161364A patent/JP2014208707A/ja active Pending
-
2016
- 2016-07-11 JP JP2016136733A patent/JP2017019786A/ja active Pending
-
2017
- 2017-04-21 US US15/493,344 patent/US20180066007A1/en not_active Abandoned
-
2018
- 2018-01-24 JP JP2018009418A patent/JP2018104437A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007525520A5 (https=) | ||
| EA002440B1 (ru) | С-4"-замещенные макролидные производные | |
| KR102401963B1 (ko) | 면역조절제 화합물 | |
| EP3362443B1 (en) | Compounds useful as immunomodulators | |
| DE69430586T2 (de) | Aminoalkanester von rapamycin | |
| ES2566368T3 (es) | Derivado de macrólido sustituido en la posición C-4'' | |
| ME00876B (me) | 4"supstituisani-9-deokso-9a-aza-9a-homoeritromicin a derivati | |
| JP2009506075A5 (https=) | ||
| RU96122172A (ru) | Гидроксиэфиры рапамицина, способ их получения и содержащие их фармацевтические композиции | |
| ES2218604T3 (es) | Derivados triciclicos de eritromicina. | |
| AU769006B2 (en) | Macrolides with anti-inflammatory activity | |
| EA005156B1 (ru) | 13-членные азалиды и их применение в качестве антибиотических агентов | |
| KR102428718B1 (ko) | 신규 화합물, 이의 제조방법 및 이를 포함하는 항생제 조성물 | |
| JP2009506066A5 (https=) | ||
| EP1025114B1 (en) | 3'-n-modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity | |
| EP2145886A1 (en) | Twelve-membered cyclomacrolactam derivative | |
| BG104425A (bg) | 6,11-мостови еритромицинови производни | |
| EP1710248A1 (en) | Novel aminoglycoside antibiotic effective against methicillin resistant staphylococcus aureus (mrsa) | |
| CA2367319A1 (en) | Erythromycin derivatives | |
| JPH0517240B2 (https=) | ||
| JP2007509980A5 (https=) | ||
| CN1235608A (zh) | 烷基化的雷帕霉素衍生物 | |
| RU2248970C2 (ru) | Циклоалкилзамещенные производные аминометилпирролидина и антибактериальный агент на их основе | |
| CA3175087A1 (en) | Immunomodulating o-het/aryl azalides | |
| JPWO2007142150A1 (ja) | 新規アミノグリコシド系抗生物質 |